Progress in Drug Research / Fortschritte Der Arzneimittelforschung / Progrès Des Recherches Pharmaceutiques 1984
DOI: 10.1007/978-3-0348-7118-1_8
|View full text |Cite
|
Sign up to set email alerts
|

The role of adipose tissue in the distribution and storage of drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

6
39
0

Year Published

1991
1991
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(45 citation statements)
references
References 98 publications
6
39
0
Order By: Relevance
“…This suggests xenobiotic metabolism in adipose tissue and its importance in determining the elimination of lipophilic compounds from the tissue (and also from the body). This hypothesis is consistent with metabolismresistant TCDD having an extremely long half-life (Bickel, 1984;Flesch-Janys et al, 1996;Michalek et al, 1996).…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…This suggests xenobiotic metabolism in adipose tissue and its importance in determining the elimination of lipophilic compounds from the tissue (and also from the body). This hypothesis is consistent with metabolismresistant TCDD having an extremely long half-life (Bickel, 1984;Flesch-Janys et al, 1996;Michalek et al, 1996).…”
Section: Discussionsupporting
confidence: 85%
“…Even with this sophisticated drug-excreting system, however, a number of highly lipophilic environmental contaminants or pharmaceutical drugs, such as TCDD and its related compounds (i.e., dioxins), polychlorinated biphenyls, 1,1-dichloro-2,2-bis-( p-chlorophenyl)ethylene, and amiodarone, are eventually accumulated at high levels in white adipose tissue (WAT). These compounds demonstrate long half-lives in the body (tissue) on the order of months to years (Bickel, 1984;Latini et al, 1984;Muhlebach et al, 1985;Flesch-Janys et al, 1996;Michalek et al, 1996). Because some of these compounds are considered endocrine disruptors, their effects on development and reproduction as well as cellular and metabolic toxicity have been studied intensively (Birnbaum, 1995;Longnecker et al, 1997).…”
mentioning
confidence: 99%
“…This view is supported by work of Bickel et al, who have found that in vitro drug accumulation in adipose tissue slices does indeed show a good correlation with log P. 15,16 It was surprising therefore that drug tissue distribution studies in vivo show no correlation between adipose tissue build-up and lipophilicity. 17,18 In vivo it appears the key factor determining the occurrence and extent of adipose tissue storage is the binding competition between adipose tissue, lean tissues, and blood plasma proteins. It was suggested that whereas adipose tissue binding is related mainly to log P, blood and lean tissue binding is determined by log P and the drugs molecular structure.…”
Section: Resultsmentioning
confidence: 99%
“…It was suggested that whereas adipose tissue binding is related mainly to log P, blood and lean tissue binding is determined by log P and the drugs molecular structure. 18 Bickel introduced the concept of Adipose Tissue Storage Index, ASI, to quantify tissue distribution of drugs. The ASI was defined as where C ad max is the maximum concentration in adipose tissue after a single dose and D ad max is the hypothetical (average) concentration of evenly distributed drug at t ) t ad max .…”
Section: Resultsmentioning
confidence: 99%
“…However, Bickel (1984) summarized a tremendous amount of data related to the distribution and storage of drugs and found that basic drugs such as chlorpromazine and imipramine do not accumulate in adipose tissue despite their high lipophilicity. Moreover, it was reported that there were large differences in the pharmacokinetics of lipophilic model compounds.…”
Section: Discussionmentioning
confidence: 99%